Coencapsulation of doxorubicin and curcumin in liposomes modified with folic acid for reversal of drug resistance in glioma - Top-Institutions - MDSpire

Coencapsulation of doxorubicin and curcumin in liposomes modified with folic acid for reversal of drug resistance in glioma

  • By

  • Zhan Wang

  • Ze Zhao

  • Yang Yang

  • Yi Zhao

  • June 17, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Neuro-Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Neuro-Oncology

  • #3

    Institute for Drug Development at The University of Texas Health Science Center at San Antonio
    Institute for Drug Development at The University of Texas Health Science Center at San Antonio

    San Antonio, Texas

    Key Differentiators

    • Oncology
    • Drug Development

  • #4

    Mays Cancer Center
    Mays Cancer Center

    San Antonio, Texas

    Key Differentiators

    • Oncology

  • #5

    State University of Campinas
    State University of Campinas

    São Paulo, Brazil

    Key Differentiators

    • Oncology
    • Cell Biology

Original Source(s)

Coencapsulation of doxorubicin and curcumin in liposomes modified with folic acid for reversal of drug resistance in glioma

  • by Zhan Wang, Ze Zhao, Yang Yang, Yi Zhao

  • June 17, 2026

Related Content

Optical coherence tomography features and visual prognosis in vitreoretinal lymphoma: a structured phenotyping study

Multimodal echocardiographic techniques in the diagnosis of cardiac tumors: applications and recent advances

The regulatory roles of dysregulated lactate dehydrogenase A in anti-tumor immunity within immune cells